Reports have characterized IL-1β activation in response to Aβ [38, 61, 67], but our study evaluated the role of CASP11 for the first time as a new molecular player in the highly complex multi-protein process required for IL-1β activation and release in AD. The gene discussed is IL1B; the disease is Alzheimer disease.